| Tag | Content |
|---|
EnhancerAtlas ID | HS145-01692 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr1:161699800-161700640 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr1:161699848-161699863 | TGAACTCCTGACCTC | - | 6.22 | | TBX21 | MA0690.1 | chr1:161700095-161700105 | TTCACACCTT | - | 6.02 | | TBX2 | MA0688.1 | chr1:161700094-161700105 | ATTCACACCTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_56629 | chr1:161698532-161702049 | u87 | | SE_58760 | chr1:161674084-161711741 | Ly1 | | SE_59497 | chr1:161674276-161714796 | Ly3 | | SE_61570 | chr1:161674449-161712145 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161729 | chr1 | 161699268 | 161701012 |
|
Enhancer Sequence | TTGTATTTTT GTAGAGACGG GGTTTCACCG TGTTGGCCAG GCTGGTCTTG AACTCCTGAC 60
CTCAGGTGAT CCACCTGCCT CAGCCTCCCA AAGTGCAGGG ATTACAGGCT TGGGCCACCG 120
CGCCCGGCCG GTTTCTGCCA TCTTGATATA GACAGGAAGT GACTAACATT AGTGGCAAGA 180
GGCTTAGTAA TCAAAGAATC TCAGGTCATT TAAAAAATCA GTTGATCATT TTTTAAGAGT 240
ACAAAAAAGA GAAATAGTTA CTCAAAGGAG AGCTAGGGCA GCAGTATCTC TTTCATTCAC 300
ACCTTTTTGG CAACATCAAC ATCCTTGTTC TTGTTTTGCC ATCTACTTCC ATTTAGAACT 360
AGGATGCGGG GGGATGGGGA AGAACAAGGA CTTTTTGGTG AGAGTGAAAA TCATTCATGA 420
CTCAACTTTC TGGTGTAGGG GAGAGGAATT GACTCATATG GCCTGTAGAC TCCACTGTCT 480
TCTTCGTGTA CCCCAGCTTT TAAGAGGAGG GCAGGATCAA GATGATCTTC TAAGATATCT 540
GTTATTGATC TCCCAGGAAG ACCTGCATTA AGGAAATATC AGCTTCATCT TCATCCCTTT 600
TGTTTGAGGT TCCTACATGC ATTTAGGGAA ACCAGAAGGC TAGCTAGCCC AGGTTGTCCA 660
AGGGGACTCT CAGAGCTCAT TCCCAAACAG CAGGGATGGC AGAAAAATGC TGGAGAAACC 720
TAGGGAGGAA TCTGCTTCTC TCTGATACTC TGATCAGTTT GGTGTCTCAG ACTTAGGCTG 780
CAAACCCTAA TCCTGCGGCT GTCCATAGCA GATGCCAGAC AAGGAACCCC AATGTCCGCT 840
|
